Editorial: Mesalamine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn? Authors' Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15285
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Mesalazine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Tofacitinib and Biologics for Moderate-To-Severe Ulcerative Colitis-What Is Best in Class? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Faecal Microbiota Transplantation for Ulcerative Colitis-Not Quite There Yet? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Yoga for QoL in Ulcerative Colitis-Any Better Than Other Supportive Activities? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

What Can We Learn From Liver?

2016English

Confidentiality in Mediation - What Can We Learn ?

2018English

What Can We Learn About Wellbeing in School?

The Journal of Student Wellbeing
2011English

What Can We Learn From Bobtail Squid?

2019English

What Can We Learn From Numerical Data?

Cardiology in the Young
PediatricsCardiologyPerinatologyCardiovascular MedicineMedicineChild Health
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy